© 2023 by Focus Medical Communications, Inc.
Goal: The symposium will feature an interactive format to enhance the educational impact. Internationally renowned gastroenterologists and selected advanced practice providers (APPs) in the management of IBD will lead the development of educational content and will serve as program faculty. The symposium will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with IBD.
Target Audience: The symposium will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with IBD to gastroenterologists, gastroenterology nurses, nurse practitioners and physician assistants.
Upon completion of this educational activity, participants should be able to:
Describe key clinical, endoscopic, and laboratory signs and symptoms of IBD
Summarize current approaches for diagnosing IBD
Implement evidence-based IBD treatment pathways to optimize the use of conventional and newer therapies in IBD patients
Describe current recommendations for health maintenance in IBD patients
Collaborate effectively with practitioners of various disciplines to optimize the care of IBD patients
Utilize practical tools for managing access barriers and facilitating timely approval of therapies in IBD
In support of improving patient care, this activity has been planned and implemented by Annenberg Center for Health Sciences at Eisenhower and Focus Medical Communications. Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences at Eisenhower designated this live activity for a maximum of 5.50 ANCC contact hours, which includes 2.0 pharmacology credits.
Disclosure of Relevant Financial Relationships:
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience all relevant financial relationships related to the content of the presentation or enduring material. Full disclosure of all relevant financial relationships will be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower and Focus Medical Communications have no relationships to disclose.
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all relevant financial relationships that could arise as a result of individuals who control activity content and who have relevant financial relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with relevant financial relationships that can be reconciled with the goals and educational integrity of the CE activity.
All of the relevant financial relationships disclosed during the course of this activity have been mitigated.
The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact us prior to the event at www.insandoutsofibd.org.
Supported by educational grants from Pfizer Inc., Takeda Pharmaceuticals U.S.A., Inc., and Janssen Biotech, Inc.